HBW
SILK

Hazlett, Burt & Watson’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Hazlett, Burt & Watson’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,150
Closed -$31K – 760
2024
Q2 		$31K Hold
1,150
– – 0.02% 398
2024
Q1 		$21K Hold
1,150
– – 0.01% 430
2023
Q4 		$14K Hold
1,150
– – 0.01% 464
2023
Q3 		$17K Sell
1,150
-225
-16% -$4.68K 0.01% 435
2023
Q2 		$44K Hold
1,375
– – 0.03% 323
2023
Q1 		$55K Hold
1,375
– – 0.05% 265
2022
Q4 		$73K Buy
1,375
+100
+8% +$4.87K 0.06% 227
2022
Q3 		$58K Hold
1,275
– – 0.06% 247
2022
Q2 		$47K Hold
1,275
– – 0.04% 279
2022
Q1 		$53K Buy
+1,275
New +$44.9K 0.04% 280

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hazlett, Burt & Watson's SILK Position: Q3 2024 in Review

Hazlett, Burt & Watson sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 1,150 shares — an estimated $31K sold.

Hazlett, Burt & Watson first reported a position in SILK in Q1 2022 and held it in 10 quarters. The position peaked at $73K in Q4 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Hazlett, Burt & Watson reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 1,150 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $31K.
  • Hazlett, Burt & Watson first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
  • Hazlett, Burt & Watson's Silk Road Medical, Inc. Common Stock position peaked at $73K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2024, filed 30 Oct 2024.